The agreement pairs Croda’s global footprint and “smart science” approach with Amino’s precision manufacturing capabilities
The new site will produce next-generation synthetic medicine active pharmaceutical ingredients
Zyrifa is indicated for patients with bone metastases stemming from a wide range of solid tumors
The collaboration will establish the MUMPMP–Agilent BioDiscovery Hub
Freenome expects the combined company to receive approximately $330 million in proceeds at closing
Acromegaly, a rare chronic endocrine disorder caused by excess growth hormone, is seeing promising advances in treatment development
NAEH can cause heavy or abnormal bleeding and, if left untreated, may progress to uterine cancer
Biocon will acquire the residual stake held by Mylan (Viatris) for a total consideration of US$ 815 million
The center will offer training to super-specialist doctors and healthcare professionals in various fields
Granules Consumer Health serves as Granules’ front-end division for OTC products in the US
Subscribe To Our Newsletter & Stay Updated
